When it comes to the law of universality, the greatest question is how the immune system can act with specificity? That is, how can it produce highly-specialized antibodies that effectively destroy distinct threats, or, as they are called, antigens?
Well, to answer this question we’ll have to retrace the steps of the scientists who first proposed the theory of specificity and the law of universality. That path began with the German scientist Paul Ehrlich, the first person to develop a theory that explained specificity.
In 1901, Ehrlich proposed the idea that antibodies are similar to the molecules that antigens prey on. The logic being that the antigens would get tricked into approaching the antibodies, who would then attack them. Since they’re found in the blood, these antibodies could bind to antigens before the antigens reached the cells they intended to destroy.
However, Ehrlich’s theory had a serious flaw.
Its prediction was that the world of antigens was quite limited, confined to the molecules that could bind to the cells they were targeting. But just a few years later it was found that practically any chemical compound, when paired with a protein, could be an antigen. Therefore, the universe of antigens is virtually unlimited and Ehrlich’s belief was unfounded.
In the 1950s, the scientists David Talmage and Frank Macfarlane Burnet came up with a better theory of specificity that was based on lymphocytes, the white blood cells that are essential to adaptive immune responses.
They reasoned that each lymphocyte has a different antigen-recognition receptor and that there are a limited number of lymphocytes that can recognize any given antigen. So, when a specific antigen enters the body and is identified by its specific lymphocyte, specific antibodies are activated by being produced, or “cloned,” in vast quantities. This theory, referred to as clonal selection, is now widely accepted by the medical community.
The law of tolerance is about preventing immune responses from harming the body itself.
It’s only common sense: a gun in the home increases the chances of someone being shot. But what prevents the body’s arsenal – that is, antibodies – from being turned on the body itself?
Actually, while such attacks do happen, immunity’s second law, the law of tolerance, usually prevents such catastrophes. It does this by sending specific cells that deter the body from self-attacking.
So, while immune-system dysfunctions that cause antibodies to attack the host, or autoimmune responses, do sometimes occur, they’re normally prevented by specific cells. These cells are called regulatory T cells, or “Tregs,” for short. Tregs work by regulating the standard T cells, which are capable of killing cells infected by viruses.
In fact, a failure to generate Tregs is what causes people to experience autoimmune responses. For instance, a 2002 paper by the scientists R.S. Wildin, S. Smyk-Pearson and A.H. Filipovich detailed the unfortunate story of a boy who, shortly after birth, succumbed to a series of autoimmune responses, type 1 diabetes among them.
He soon had a middle-ear infection, followed by diarrhea and pneumonia. It was found that his medical problems were a result of a genetic mutation that prevented his body from developing Tregs.
But this isn’t just a human problem. In fact, autoimmune responses have also been found in experiments on rats. For example, in the early 2000s, the Oxford scientists Fiona Powrie and Don Mason did experiments on a specific breed of rats called “nude rats,” which have been found to not develop a T-cell immune system.
When the scientists transferred T cells, without Tregs, from normal rats to nude rats, the rodents experienced a range of autoimmune responses, thereby showing that Tregs are necessary to keep the potentially self-destructive power of T cells under control.
The third law of immunity states that each pathogen requires an appropriate immune response.
Did you know that pathogens, the things that cause disease, can live anywhere in the human body and cause disease for a wide variety of reasons? It’s true, and while some are explicitly toxic to the cells of our bodies, causing infections and immediate destruction, others enter cells and live inside them, often changing the function of the cell altogether and leading to diseases like cancer.
So, since every pathogen is different, they each require their own immune response, which brings us to the third law of immunity – the law of appropriateness.
For instance, we now know that an immune response requires the appropriate pathogen-killing T cells. Richard Locksley, a scientist and physician at the University of California, San Francisco, has shown that the use of the appropriate T cells in an immune response is absolutely essential.
Locksley took mice that were infected with a parasite known as Leishmania major. Some of the animals managed to get the infection under control, but others did not. What Locksley proved was that this difference in immunity was not a result of the intensity of the response but rather a result of how appropriate to the parasite the T cells of any given mouse were.
So, why did some rodents have a more appropriate response than others?
It has to do with the strength of a specific cell. That’s because there are specialized cells that interpret threats and spur the correct immune response. These cells are known as dendritic cells and they are key players in T cell activation, found in just about every bodily tissue.
Their power lies in a special recognition mechanism that reads the nature of a threat before ordering T cells to launch the appropriate immune response. For example, say your body is infected with the flu. The dendritic cells in your body will recognize the virus for what it is and find the T cells best suited to destroy it.
The immune system might even be able to fight off cancer.
The fight against cancer is one of modern medicine’s greatest undertakings. This malignant form of tumor, an abnormal growth of bodily tissue, has largely stumped doctors and scientists, but they now believe that the immune system may offer a cure.
In fact, building immunity can actually slow the development of tumors. For instance, a study done in Taiwan found that hepatitis-B vaccination has remarkably reduced the incidence of liver cancer.
The study showed that people born between 1975 and 1976, before the vaccine was introduced, had an annual liver cancer rate of 0.64 per 100,000. But for those born between 1985 and 1986, when the vaccine was used commonly, the rate had fallen to just 0.1 – an 84-percent decrease!
Well, the vaccine could have produced an immune response that reduced cancer risk. But that’s not the only example of immunity fighting off tumors. A 1950s experiment done by Richard Prehn and Joan Main at the Public Service Hospital of Seattle is another good example.
The study found that tumors could contain specific antigens, molecules that cause an immune response, and that cancers could be fought through the production of the correct antibodies.
The scientific pair exposed mice to a chemical that was known to cause cancer in rodents. Then, when the tumors of the mice had reached a predetermined size, the scientists would remove them surgically. A few days later the tumors were returned to the cancerous mice and also implanted in non-cancerous mice.
In ten out of the twelve specimens, the tumors grew in the previously non-tumorous mice, but were rejected by the mice from whom they had been removed. The implication is that the formerly cancerous mice developed an immunity to this particular type of tumor.
Studies like this are a beacon of hope that an immunity to cancer is on the horizon!
Interaction between microbiota and immunity
In the gut, skin, and other mucosal environments of the body, an immense number of microbes are present, collectively called a microbiome.
During the past two decades, the genomes of bacteria and other microorganisms in this ecosystem, including fungi, viruses, parasites, have been increasingly investigated, facilitated by rapid developments in culture-independent genomics.
The gut microbiome plays an active role in the circadian rhythm, nutrient regulation, metabolism, and immunity of hosts through its positive influence on the gut microbiome. Recent advances in microbiome research verify this notion.
The mammalian immune system is comprised of a complex network of innate and adaptive components that play a crucial role in host defence against potentially harmful external agents and endogenous perturbations of homeostasis. In terms of ecology, mammals and their commensal microbes co-evolved toward mutualization and hemostasis.
To maintain immune tolerance to innocuous stimuli during such intimate relationships, host immunity needs to function correctly in order to keep commensals from overexploiting host resources.
A disturbed gut microbiome results in systemic diffusion of commensal microorganisms, susceptibility to pathogenic invasion, and aberrant immune responses when perturbed by environmental incursions (such as antibiotic use, diet changes, and changes in geography).
In order for your gut to be healthy, it needs a healthy balance of bacteria. That’s why there are so many different probiotic supplements available today. But it’s crucial to pick a supplement with a diverse range of bacterial strains.
The supplement Biofit, for example, claims to contain billions of CFU and diverse types of bacteria. It might benefit those who are bloated or have a lowered immunity, as well as those who are overweight or underweight. However, you should read some Biofit reviews before making any purchase because the supplement industry is rife with scams.
Besides, it’s always best to talk with your doctor before you start taking a supplement, especially if you already take medications, have health concerns or are pregnant.
The human immune system is a remarkable gift of biology, but a dysfunctional immune system can be just as dangerous as a healthy one is protective. By studying immunity, scientists have discovered remarkable cures to a variety of diseases and may even be on their way to ending cancer.